(Total Views: 522)
Posted On: 02/28/2020 11:02:45 PM
Post# of 153986
I believe 2 years is the standard for PFS for cancer trials. Here is the primary endpoint for PFS:
“Phase II: Progression free survival (PFS) defined as time in months from the date of first study treatment to the date of disease progression or death from any cause, whichever comes first. [ Time Frame: Every 6 to 9 weeks after study start, until progression or death, assessed up to 2 years after completion of treatment ]”
Don’t read into it too much.....I think this is just standard trial protocol...and IMO if these TNBC patients are all still alive and testing for 0 CTCs in 2 years CYDY will be $40+ and considered the SOC for TNBC (and likely many other cancers)!
“Phase II: Progression free survival (PFS) defined as time in months from the date of first study treatment to the date of disease progression or death from any cause, whichever comes first. [ Time Frame: Every 6 to 9 weeks after study start, until progression or death, assessed up to 2 years after completion of treatment ]”
Don’t read into it too much.....I think this is just standard trial protocol...and IMO if these TNBC patients are all still alive and testing for 0 CTCs in 2 years CYDY will be $40+ and considered the SOC for TNBC (and likely many other cancers)!
(1)
(0)
Please do your own due diligence. All my posts and comments are not to be considered investment advice.
